Harvard Bioscience Inc expected to post earnings of 7cents a share - Earnings Preview

Harvard Bioscience

05/11/2022 03:08

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
8. 
    * The Holliston Massachusetts-based  company is expected to
report
 a 2.6% decrease in revenue to $28.89 million from $29.66
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harvard Bioscience
Inc is
for earnings of 7 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $7​, above​ its last closing price of $2.54.
​​​

This summary was machine generated November 5 at 03:07 GMT.  All
figures in US dollars  unless otherwise stated